Journal
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY
Volume 7, Issue 10, Pages 178-183Publisher
BAISHIDENG PUBLISHING GROUP INC
DOI: 10.4251/wjgo.v7.i10.178
Keywords
Colorectal cancer; Screening; Fecal DNA; Cologuard (R); Adenoma
Categories
Ask authors/readers for more resources
The early detection of colorectal cancer with effective screening is essential for reduction of cancer-specific mortality. The addition of fecal DNA testing in the armamentarium of screening methods already in clinical use launches a new era in the noninvasive part of colorectal cancer screening and emanates from a large number of previous and ongoing clinical investigations and technological advancements. In this review, we discuss the molecular rational and most important genetic alterations hallmarking the early colorectal carcinogenesis process. Also, representative DNA targets-markers and key aspects of their testing at the clinical level in comparison or/and association with other screening methods are described. Finally, a critical view of the strengths and limitations of fecal DNA tests is provided, along with anticipated barriers and suggestions for further exploitation of their use.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available